Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ee1f2823cfb50f8cebb69de7f074d4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98ccee990e5fbd8e8dc9eb95473ec517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_639cde93ad25c4794ecf02278c933fa2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2809 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
filingDate |
2018-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_050f863928d91890dfe911693cae9588 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e89cf7ebfb846108ff28087aa3968b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8c4410ec50c8537d716cd467c110f46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fa99fdf315a78e4ee49b8359314274c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_331f8c9f0862bc86b617f496e4f2d0bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9e4ed3fb6375b464701e2b6871103bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_685460783b547f472d4a90fbcb53e9f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0184c590519f59283541ebfdbd918217 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_272d4649228afd8f6b462460e756107c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e073fc7036f7f57ad595b0f6e136eba |
publicationDate |
2019-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2019055311-A1 |
titleOfInvention |
Agents for Treatment of Claudin Expressing Cancer Diseases |
abstract |
The present invention provides binding agents that contain n binding domain that is specific for CD3 allowing binding to T cells and a binding domain that is specific for a tumor-associated claudin molecule and methods of using these binding agents or nucleic acids encoding therefor for treating cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10745477-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018162938-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11628223-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11583590-B2 |
priorityDate |
2012-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |